Press Release - Company Data

Oculus Innovative Sciences Announces Board of Directors Restructuring Following Ruthigen IPO
Posted 2014-04-02 06:32NAI Editing
today announced the closing of its subsidiary, Ruthigen, Inc.'s (Nasdaq:RTGN), initial public offering on the NASDAQ Capital Market on March 26, 2014.

Oculus Innovative Sciences Announces Appointment of Sharon Barbari to Its Board of Directors
Posted 2014-03-27 00:00NAI Editing
today announced the appointment of Sharon Barbari to its board of directors, effective March 26, 2014.

Oculus Innovative Sciences Announces Appointment of Russell Harrison to Board of Directors
Posted 2014-02-27 00:03NAI Editing
today announced the appointment of Russell ("Russ") Harrison to its board of directors, effective February 26, 2014.

Oculus Innovative Sciences Receives Approval for Oral and Throat Infection Products in Mexico
Posted 2014-02-18 23:26NAI Editing
a global healthcare company that designs, manufactures and markets prescription and non-prescription products in 31 countries, today announced a regulatory approval in Mexico for the company's new Mic

Oculus Innovative Sciences Receives European CE Mark for Use of Microcyn(R) in the Topical Treatment of Mild to Moderate Acne
Posted 2014-02-03 23:42NAI Editing
a global healthcare company that designs, manufactures and markets prescription and non-prescription products in 31 countries, today announced receipt of the European CE Mark for the Microcyn®-based

Oculus Innovative Sciences Receives Notification of Compliance With the Stockholders' Requirement of the NASDAQ Listing Rules
Posted 2013-12-29 23:49NAI Editing
today announced it received a determination letter from the listing qualifications department of the NASDAQ Stock Market LLC ("NASDAQ") notifying the company that it is now compliant with the stockho

Oculus Innovative Sciences Pays Off Debt to Strengthen Balance Sheet; Obtains $4.5 Million in Stockholders' Equity on a Pro Forma Basis as of September 30, 2013, Sufficient to Regain Compliance with NASDAQ Listing Rules
Posted 2013-12-18 23:36NAI Editing
In a transaction on October 30, 2012, Oculus agreed to issue $3.5 million dollars of restricted common stock to its primary lender, Venture Lending and Leasing (VLL), which agreed to reduce the compa

Oculus Innovative Sciences Receives Mexican Ministry of Health Approval of Microcyn(R)-Based Hydrogel for Management of Scars
Posted 2013-12-11 23:33NAI Editing
a global healthcare company that designs, manufactures and markets prescription and non-prescription products 27 countries, today announced a regulatory approval in Mexico for the company's new Micro

Oculus Innovative Sciences Receives FDA Clearance for Microcyn(R) Scar Management HydroGel
Posted 2013-12-03 23:37NAI Editing
a global healthcare company that designs, manufactures and markets prescription and non-prescription products in 27 countries, today announced that it has received a new 510(k) clearance from the U.S

Oculus Innovative Sciences Announces Allowance of New Patent in Mexico for Novel Solution for Use in Invasive Surgical Procedures
Posted 2013-07-01 23:45NAI Editing
a global healthcare company that designs, manufactures and markets prescription and non-prescription products in 27 countries, today announced the allowance of a Mexican patent for the use of the com